Salwa Mahmoud Elwasif
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Salwa Mahmoud Elwasif has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abdel-Hady El-Gilany
Department of Public Health, Faculty of Medicine, Mansoura University, Mansoura, Egypt
1 shared publication - Eman Salah El-Shafey
Biochemistry Department, Faculty of Science, Damietta University, Damietta, Egypt
1 shared publication - Eslam Samy Elsherbiny
Biochemistry Department, Faculty of Science, Damietta University, Damietta, Egypt
1 shared publication - Marwa H. Elnagdy
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura City 35516, Egypt
1 shared publication Mohamed Elbogdady
Oncology Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt
1 shared publicationMona S. Abdelhafez
Medical Microbiology and Immunology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
1 shared publication
Latest Publications
- 23 January 2026
- Published by Elsevier in American Journal of Infection Control
- Vol. 54 (7) , 778-784
Immunity to varicella zoster virus among health care workers in transplantation units
- 23 January 2026
- Published by Elsevier in American Journal of Infection Control
- Vol. 54 (7) , 778-784
Immunity to varicella zoster virus among health care workers in transplantation units
- 17 August 2020
- Published by Taylor & Francis in Immunological Investigations
- Vol. 50 (8) , 1072-1084
Impact of Proinflammatory Cytokine Gene Polymorphisms and Circulating CD3 on Long-Term Renal Allograft Outcome in Egyptian Patients
The extant study aimed to explore the influence of two cytokines TNF-α − 308 and IFN-γ + 874 gene polymorphism on development of renal transplant rejection and to investigate the feasibility of Th1 cytotoxic immune reaction (CD3). It includes 152 kidney recipients were divided into two subgroups: 76 stable graft functions (SGF) and 76 allograft dysfunctions (AD) compared with 56 healthy individuals as control group. TNF-α − 308 G > A and IFN-γ + 874 A > T genetic polymorphisms were characterized using ARMS-PCR technique. CD3 protein expression was measured using ELISA Kit. The effect on transplant outcome was analyzed where, statistically significant differences of TNF-a-308 G/A were observed between AD group when compared to SGF group (OR = 0.296, 95% CI = 0.091–0.965, p = .031) in AG genotype (intermediate producer genotype). Also, AD group displayed a statistically significant increase of IFN-γ + 874 TT (high producer genotype) when compared to SGF group (OR = 0.290, 95% CI = 0.127–0.665, p = .003). The expression of CD3+ T lymphocytes in recipients with allograft dysfunction was statistically higher than that with stable allograft function and control groups (732 ± 76, 235 ± 51 and 442 ± 50) respectively and (p ≤ 0.001). In conclusion, IFN-γ + 874 T and TNF-α − 308 A alleles are risk alleles for renal transplant rejection and these two single nucleotide polymorphisms (SNPs) may be implicated in the tendency of rejection after renal transplantation. CD3 may be used as non-invasive biomarker in monitoring of rejection and avoid exposing patients for biopsy risks and sampling error.
- 17 August 2020
- Published by Taylor & Francis in Immunological Investigations
- Vol. 50 (8) , 1072-1084
Impact of Proinflammatory Cytokine Gene Polymorphisms and Circulating CD3 on Long-Term Renal Allograft Outcome in Egyptian Patients
The extant study aimed to explore the influence of two cytokines TNF-α − 308 and IFN-γ + 874 gene polymorphism on development of renal transplant rejection and to investigate the feasibility of Th1 cytotoxic immune reaction (CD3). It includes 152 kidney recipients were divided into two subgroups: 76 stable graft functions (SGF) and 76 allograft dysfunctions (AD) compared with 56 healthy individuals as control group. TNF-α − 308 G > A and IFN-γ + 874 A > T genetic polymorphisms were characterized using ARMS-PCR technique. CD3 protein expression was measured using ELISA Kit. The effect on transplant outcome was analyzed where, statistically significant differences of TNF-a-308 G/A were observed between AD group when compared to SGF group (OR = 0.296, 95% CI = 0.091–0.965, p = .031) in AG genotype (intermediate producer genotype). Also, AD group displayed a statistically significant increase of IFN-γ + 874 TT (high producer genotype) when compared to SGF group (OR = 0.290, 95% CI = 0.127–0.665, p = .003). The expression of CD3+ T lymphocytes in recipients with allograft dysfunction was statistically higher than that with stable allograft function and control groups (732 ± 76, 235 ± 51 and 442 ± 50) respectively and (p ≤ 0.001). In conclusion, IFN-γ + 874 T and TNF-α − 308 A alleles are risk alleles for renal transplant rejection and these two single nucleotide polymorphisms (SNPs) may be implicated in the tendency of rejection after renal transplantation. CD3 may be used as non-invasive biomarker in monitoring of rejection and avoid exposing patients for biopsy risks and sampling error.